Brief Research Report

Published on 17 Aug 2021

Retrospective Observational Study of Daytime Add-On Administration of Zopiclone to Difficult-to-Treat Psychiatric Inpatients With Unpredictable Aggressive Behavior, With or Without EEG Dysrhythmia

in Psychopharmacology

Alfonso Ceccherini-Nelli
Elena Bucuci
Lisa Burback
Daniel Li
Maryam Alikouzehgaran
Zahid Latif
Kevin Morin
Karthikeyan Ganapathy
Manhaz Salsali
Ubaid Abdullah

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.693788

3,565 views
3 citations

Review

Published on 11 Aug 2021

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy

in Psychopharmacology

Maria Eleni Eleftheriou
Emily Thomas

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.707057

9,873 views
13 citations

Review

Published on 10 Aug 2021

D-Serine: A Cross Species Review of Safety

in Psychopharmacology

Amir Meftah
Hiroshi Hasegawa
Joshua T. Kantrowitz

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.726365

7,688 views
15 citations

Original Research

Published on 04 Aug 2021

Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model

in Psychopharmacology

Roberto Farina Almeida
Yasmine Nonose
Marcelo Ganzella
Samanta Oliveira Loureiro
Andréia Rocha
Daniele Guilhermano Machado
Bruna Bellaver
Fernanda Urruth Fontella
Douglas T. Leffa
Letícia Ferreira Pettenuzzo

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.701408

2,751 views
8 citations

Perspective

Published on 02 Aug 2021

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

in Psychopharmacology

Nicolas Langlitz
Erika Dyck
Milan Scheidegger
Dimitris Repantis

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.680064

8,442 views
17 citations

Original Research

Published on 26 Jul 2021

Characteristic and Early Discontinuation of Obsessive-Compulsive Disorder Trials Registered on ClinicalTrials.gov

in Psychopharmacology

Shanxia Luo
Qiong Guo
Liu Yang
Yifan Cheng
Youlin Long
Xinyi Wang
Liqin Liu
Zixin Yang
Tengyue Hu
Liang Du

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.650057

2,406 views
2 citations

Case Report

Published on 22 Jul 2021

Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder

in Psychopharmacology

Maximilian Meyer
Marc Walter
Stefan Borgwardt
Alexandra Scheidegger
Elisabeth Lang
Patrick Köck

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.712110

4,038 views
2 citations

Original Research

Published on 22 Jul 2021

Developmental Alcohol Exposure in Drosophila: Effects on Adult Phenotypes and Gene Expression in the Brain

in Psychopharmacology

Sneha S. Mokashi
Vijay Shankar
Rebecca A. MacPherson
Rachel C. Hannah
Trudy F. C. Mackay
Robert R. H. Anholt

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.699033

4,227 views
11 citations

Hypothesis and Theory

Published on 19 Jul 2021

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

in Psychopharmacology

Rita Kočárová
Jiří Horáček
Robin Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.661233

15,196 views
36 citations

Original Research

Published on 16 Jul 2021

Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor

in Psychopharmacology

Xuan Ju
Shengdong Wang
Pan Yan
Chunyan Zhu
Xiwen Hu
Jiezheng Dong
Zhonglin Tan

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.599399

3,462 views
5 citations

Brief Research Report

Published on 05 Jul 2021

Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication

in Psychopharmacology

Guoying Wang
Wolfgang Weber-Fahr
Ulrich Frischknecht
Derik Hermann
Falk Kiefer
Gabriele Ende
Markus Sack

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.656468

4,379 views
6 citations

Hypothesis and Theory

Published on 29 Jun 2021

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model

in Psychopharmacology

Ahmet Yardimci
Mehmet Ridvan Ozdede
Haluk Kelestimur

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.654616

10,406 views
5 citations

Original Research

Published on 29 Jun 2021

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

in Psychopharmacology

Keri Mans
Hannes Kettner
David Erritzoe
Eline C. H. M. Haijen
Mendel Kaelen
Robin L. Carhart-Harris

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.647909

17,007 views
14 citations

Original Research

Published on 25 Jun 2021

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis

in Psychopharmacology

Ken Kurisu
Kazuhiro Yoshiuchi

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.609678

18,147 views
1 citation

Original Research

Published on 25 Jun 2021

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

in Psychopharmacology

Sophie Lonchampt
Fabienne Gerber
Jean-Michel Aubry
Jules Desmeules
Markus Kosel
Marie Besson

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.614825

4,308 views
6 citations

Original Research

Published on 16 Jun 2021

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study

in Psychopharmacology

Dóra Révész
Genís Ona
Giordano N. Rossi
Juliana M. Rocha
Rafael G. dos Santos
Jaime E. C. Hallak
Miguel Á. Alcázar-Córcoles
José C. Bouso

Frontiers in Psychiatry

doi 10.3389/fpsyt.2021.687546

9,137 views
26 citations

Navigation group

Articles

Retrospective Observational Study of Daytime Add-On Administration of Zopiclone to Difficult-to-Treat Psychiatric Inpatients With Unpredictable Aggressive Behavior, With or Without EEG Dysrhythmia

Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy

D-Serine: A Cross Species Review of Safety

Antidepressant-Like Effects of Chronic Guanosine in the Olfactory Bulbectomy Mouse Model

Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics

Characteristic and Early Discontinuation of Obsessive-Compulsive Disorder Trials Registered on ClinicalTrials.gov

Case Report: CBD Cigarettes for Harm Reduction and Adjunctive Therapy in a Patient With Schizophrenia and Substance Use Disorder

Developmental Alcohol Exposure in Drosophila: Effects on Adult Phenotypes and Gene Expression in the Brain

Does Psychedelic Therapy Have a Transdiagnostic Action and Prophylactic Potential?

Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi via A1 Adenosine Receptor

Cortical Glutamate and GABA Changes During Early Abstinence in Alcohol Dependence and Their Associations With Benzodiazepine Medication

Agomelatine, A Potential Multi-Target Treatment Alternative for Insomnia, Depression, and Osteoporosis in Postmenopausal Women: A Hypothetical Model

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample

Comparison of Antipsychotics for the Treatment of Patients With Delirium and QTc Interval Prolongation: A Clinical Decision Analysis

Prevalence of Polypharmacy and Inappropriate Medication in Adults With Intellectual Disabilities in a Hospital Setting in Switzerland

Cross-Sectional Associations Between Lifetime Use of Psychedelic Drugs and Psychometric Measures During the COVID-19 Confinement: A Transcultural Study